ReviewChinese journal of cancer2015

The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges.

Bianca Cheaib et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.